Open-Label Phase 1 Study of PD-L1 t-haNK In Subjects With Locally Advanced Or Metastatic Solid Cancers
NCT04050709 · COMPLETED · Phase 1
We track 2 ClinicalTrials.gov studies led by Immunitybio Inc. The portfolio skews toward Phase 1 (1 trials).
2 clinical trials sponsored by Immunitybio Inc.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 1 | 1 | 50% |
| Phase 2 | 1 | 50% |
Immunitybio Inc currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 1, Phase 2.
Immunitybio Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.